SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.580-3.0%Oct 28 3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: End2War10/7/2025 3:56:33 PM
2 Recommendations

Recommended By
bobbseytwins2001
rodneyh07

  Read Replies (1) of 1216
 
10/7/25 Post on x.AI
Post

Camus




@newstart_2024


A landmark publication at ASCO 2025 has finally acknowledged the unthinkable: radiation therapy can induce metastasis, spreading the cancer it was meant to treat. This is the seismic shift in oncology revealed by Dr. Patrick Soon-Shiong. The largest gathering of global oncologists has been forced to confront a long-ignored truth about a standard treatment. The establishment's response to this revelation is a belated hope for a solution. Dr. Soon-Shiong confirms that solution is already here. His 2024-approved therapy is the first to protect a patient's natural killer cells during radiation, directly countering this newly admitted risk. The demand is immense, with thousands of patients already seeking access. But his mission is national. With FDA Expanded Access and a pivotal meeting scheduled, he is fighting to make this life-saving countermeasure available to every American—in rural towns and major cities alike—so no one is forced to travel abroad for care. This breakthrough also extends beyond oncology. It represents the foundation of a national Bioshield, a critical defense against radiological threats and bioterrorism. The paradigm for protecting public health has irrevocably changed.

And, here is another interview with PSS about this, saying, among other things, that Saudi Arabia and Quttar want Anktiva now and PSS indicates that they are going to approve it. PSS says he is meeting with the FDA "next week" and intends to discuss how to make Anktiva available for broader use in the US.

x.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News